National Health (Price and Special Patient Contribution) Amendment Determination 2023 (No. 9) (Cth)
PB 121 of 2023
National Health (Price and Special Patient Contribution) Amendment Determination 2023 (No. 9)
I, Nikolai Tsyganov, Assistant Secretary, Pricing and PBS Policy Branch, Technology Assessment and Access Division, Department of Health and Aged Care, delegate of the Minister for Health and Aged Care, make the following Determination:
Dated 30 November 2023
NIKOLAI TSYGANOV
Assistant Secretary
Pricing and PBS Policy Branch
Technology Assessment and Access Division
Department of Health and Aged Care
Contents
1 Name........................................................................................................................................ 1
2 Commencement........................................................................................................................ 1
3 Authority.................................................................................................................................. 1
4 Schedules................................................................................................................................. 1
Schedule 1—Amendments 2
National Health (Price and Special Patient Contribution) Determination 2022 (PB 98 of 2022) 2
1 Name
This instrument is the National Health (Price and Special Patient Contribution) Amendment Determination 2023 (No. 9).
This instrument may also be cited as PB 121 of 2023.
2 Commencement
(1) Each provision of this instrument specified in column 1 of the table commences, or is taken to have commenced, in accordance with column 2 of the table. Any other statement in column 2 has effect according to its terms.
| Commencement information | ||
| Column 1 | Column 2 | Column 3 |
| Provisions | Commencement | Date/Details |
| 1. The whole of this instrument | 1 December 2023 | |
Note: This table relates only to the provisions of this instrument as originally made. It will not be amended to deal with any later amendments of this instrument.
(2) Any information in column 3 of the table is not part of this instrument. Information may be inserted in this column, or information in it may be edited, in any published version of this instrument.
3 Authority
This instrument is made under section 85B of the National Health Act 1953.
4 Schedules
Each instrument that is specified in a Schedule to this instrument is amended or repealed as set out in the applicable items in the Schedule concerned, and any other item in a Schedule to this instrument has effect according to its terms.
Schedule 1—Amendments
National Health (Price and Special Patient Contribution) Determination 2022 (PB 98 of 2022)
Schedule 1 – Omit entry for Alendronic acid with colecalciferol
Omit
| Alendronic acid with colecalciferol | Tablet 70 mg (as alendronate sodium) with 70 micrograms colecalciferol | Oral | Fosamax Plus | 4 | 5.13 | 8.13 |
| Tablet 70 mg (as alendronate sodium) with 140 micrograms colecalciferol | Oral | Fosamax Plus 70 mg/140 mcg | 4 | 5.13 | 8.13 |
Schedule 1 – entry for Budesonide with formoterol
Omit
| Budesonide with formoterol | Powder for oral inhalation in breath actuated device containing budesonide 400 micrograms with formoterol fumarate dihydrate 12 micrograms per dose, 60 doses | Inhalation by mouth | Symbicort Turbuhaler 400/12 | 1 | 22.07 | 23.93 |
| Powder for oral inhalation in breath actuated device containing budesonide 200 micrograms with formoterol fumarate dihydrate 6 micrograms per dose, 120 doses | Inhalation by mouth | Symbicort Turbuhaler 200/6 | 1 | 22.33 | 26.05 |
Insert
| Budesonide with formoterol | Powder for oral inhalation in breath actuated device containing budesonide 400 micrograms with formoterol fumarate dihydrate 12 micrograms per dose, 60 doses | Inhalation by mouth | Symbicort Turbuhaler 400/12 | 1 | 22.07 | 23.93 |
| Powder for oral inhalation in breath actuated device containing budesonide 200 micrograms with formoterol fumarate dihydrate 6 micrograms per dose, 120 doses | Inhalation by mouth | Symbicort Turbuhaler 200/6 | 1 | 22.33 | 26.05 | |
| Pressurised inhalation containing budesonide 100 micrograms with formoterol fumarate dihydrate 3 micrograms per dose, 120 doses | Inhalation by mouth | Symbicort Rapihaler 100/3 | 1 | 13.40 | 15.71 | |
| Pressurised inhalation containing budesonide 200 micrograms with formoterol fumarate dihydrate 6 micrograms per dose, 120 doses | Inhalation by mouth | Symbicort Rapihaler 200/6 | 1 | 22.06 | 24.37 |
Schedule 1 – entry for Cefuroxime
Omit
| Cefuroxime | Tablet 250 mg (as axetil) | Oral | Zinnat | 20 | 5.27 | 9.71 |
Insert
| Cefuroxime | Tablet 250 mg (as axetil) | Oral | Zinnat | 20 | 5.27 | 11.16 |
Schedule 1 – entry for Donepezil
Omit
| Donepezil | Tablet containing donepezil hydrochloride 5 mg | Oral | Aricept | 28 | 7.44 | 10.16 |
| Tablet containing donepezil hydrochloride 10 mg | Oral | Aricept | 28 | 7.44 | 14.09 |
Insert
| Donepezil | Tablet containing donepezil hydrochloride 5 mg | Oral | Aricept | 28 | 7.44 | 15.20 |
| Tablet containing donepezil hydrochloride 10 mg | Oral | Aricept | 28 | 7.44 | 15.15 |
Schedule 1 – entry for Flecainide
Omit
| Flecainide | Tablet containing flecainide acetate 50 mg | Oral | Tambocor | 60 | 14.94 | 17.38 |
| Tablet containing flecainide acetate 100 mg | Oral | Tambocor | 60 | 18.52 | 20.97 |
Insert
| Flecainide | Tablet containing flecainide acetate 50 mg | Oral | Tambocor | 60 | 14.94 | 21.04 |
| Tablet containing flecainide acetate 100 mg | Oral | Tambocor | 60 | 18.52 | 25.12 |
Schedule 1 – entry for Fluticasone propionate with salmeterol
Omit
| Fluticasone propionate with salmeterol | Pressurised inhalation containing fluticasone propionate 125 micrograms with salmeterol 25 micrograms (as xinafoate) per dose, 120 doses (CFC‑free formulation) | Inhalation by Mouth | Seretide MDI 125/25 | 1 | 27.07 | 29.98 |
| Pressurised inhalation containing fluticasone propionate 250 micrograms with salmeterol 25 micrograms (as xinafoate) per dose, 120 doses (CFC‑free formulation) | Inhalation by Mouth | Seretide MDI 250/25 | 1 | 36.65 | 39.56 | |
| Powder for oral inhalation in breath actuated device containing fluticasone propionate 100 micrograms with salmeterol 50 micrograms (as xinafoate) per dose, 60 doses | Inhalation by Mouth | Seretide Accuhaler 100/50 | 1 | 28.34 | 32.06 | |
| Powder for oral inhalation in breath actuated device containing fluticasone propionate 250 micrograms with salmeterol 50 micrograms (as xinafoate) per dose, 60 doses | Inhalation by Mouth | Seretide Accuhaler 250/50 | 1 | 27.07 | 29.98 | |
| Powder for oral inhalation in breath actuated device containing fluticasone propionate 500 micrograms with salmeterol 50 micrograms (as xinafoate) per dose, 60 doses | Inhalation by Mouth | Seretide Accuhaler 500/50 | 1 | 36.65 | 39.56 | |
| Pressurised inhalation containing fluticasone propionate 50 micrograms with salmeterol 25 micrograms (as xinafoate) per dose, 120 doses (CFC‑free formulation) | Inhalation by Mouth | Seretide MDI 50/25 | 1 | 28.34 | 32.06 |
Insert
| Fluticasone propionate with salmeterol | Pressurised inhalation containing fluticasone propionate 125 micrograms with salmeterol 25 micrograms (as xinafoate) per dose, 120 doses (CFC‑free formulation) | Inhalation by Mouth | Seretide MDI 125/25 | 1 | 27.07 | 30.79 |
| Pressurised inhalation containing fluticasone propionate 250 micrograms with salmeterol 25 micrograms (as xinafoate) per dose, 120 doses (CFC‑free formulation) | Inhalation by Mouth | Seretide MDI 250/25 | 1 | 36.65 | 40.37 | |
| Powder for oral inhalation in breath actuated device containing fluticasone propionate 100 micrograms with salmeterol 50 micrograms (as xinafoate) per dose, 60 doses | Inhalation by Mouth | Seretide Accuhaler 100/50 | 1 | 28.34 | 32.06 | |
| Powder for oral inhalation in breath actuated device containing fluticasone propionate 250 micrograms with salmeterol 50 micrograms (as xinafoate) per dose, 60 doses | Inhalation by Mouth | Seretide Accuhaler 250/50 | 1 | 27.07 | 30.79 | |
| Powder for oral inhalation in breath actuated device containing fluticasone propionate 500 micrograms with salmeterol 50 micrograms (as xinafoate) per dose, 60 doses | Inhalation by Mouth | Seretide Accuhaler 500/50 | 1 | 36.65 | 40.37 | |
| Pressurised inhalation containing fluticasone propionate 50 micrograms with salmeterol 25 micrograms (as xinafoate) per dose, 120 doses (CFC‑free formulation) | Inhalation by Mouth | Seretide MDI 50/25 | 1 | 28.34 | 32.06 |
Schedule 1 – entry for Indapamide
Omit
| Indapamide | Tablet containing indapamide hemihydrate 1.5 mg (sustained release) | Oral | Natrilix SR | 90 | 6.24 | 12.03 |
Insert
| Indapamide | Tablet containing indapamide hemihydrate 1.5 mg (sustained release) | Oral | Natrilix SR | 90 | 6.24 | 13.42 |
Schedule 1 – entry for Naproxen
Omit
| Naproxen | Tablet 1 g (sustained release) | Oral | Naprosyn SR1000 | 28 | 5.41 | 6.33 |
| Tablet 750 mg (sustained release) | Oral | Naprosyn SR750 | 28 | 4.06 | 4.93 | |
| Tablet containing naproxen sodium 550 mg | Oral | Anaprox 550 | 50 | 4.55 | 6.11 |
Insert
| Naproxen | Tablet 1 g (sustained release) | Oral | Naprosyn SR1000 | 28 | 5.41 | 7.60 |
| Tablet 750 mg (sustained release) | Oral | Naprosyn SR750 | 28 | 4.06 | 6.34 | |
| Tablet containing naproxen sodium 550 mg | Oral | Anaprox 550 | 50 | 4.55 | 7.26 |
Schedule 1 – Omit entry for Ondansetron
Omit
| Ondansetron | Wafer 4 mg | Oral | Zofran Zydis | 10 | 11.04 |
| Wafer 8 mg | Oral | Zofran Zydis | 4 | 5.35 | 7.63 |
| Oral | Zofran Zydis | 10 | 15.66 |
Insert
| Ondansetron | Wafer 4 mg | Oral | Zofran Zydis | 10 | 8.75 | 11.04 |
| Wafer 8 mg | Oral | Zofran Zydis | 10 | 5.35 | 15.66 |
Schedule 1 – entry for Rosuvastatin
Omit
| Rosuvastatin | Tablet 5 mg (as calcium) | Oral | Crestor | 30 | 2.50 | 5.96 |
| Tablet 10 mg (as calcium) | Oral | Crestor | 30 | 3.50 | 6.87 | |
| Tablet 20 mg (as calcium) | Oral | Crestor | 30 | 3.55 | 6.89 | |
| Tablet 40 mg (as calcium) | Oral | Crestor | 30 | 5.06 | 9.16 |
Insert
| Rosuvastatin | Tablet 5 mg (as calcium) | Oral | Crestor | 30 | 2.50 | 7.11 |
| Tablet 10 mg (as calcium) | Oral | Crestor | 30 | 3.50 | 8.09 | |
| Tablet 20 mg (as calcium) | Oral | Crestor | 30 | 3.55 | 8.15 | |
| Tablet 40 mg (as calcium) | Oral | Crestor | 30 | 5.06 | 9.65 |
0
0
0